ATE221771T1 - Perorale zusammensetzung zur kontrollierten freisetzungen in dem unteren teil des gastrointestinaltraktes - Google Patents
Perorale zusammensetzung zur kontrollierten freisetzungen in dem unteren teil des gastrointestinaltraktesInfo
- Publication number
- ATE221771T1 ATE221771T1 AT96906784T AT96906784T ATE221771T1 AT E221771 T1 ATE221771 T1 AT E221771T1 AT 96906784 T AT96906784 T AT 96906784T AT 96906784 T AT96906784 T AT 96906784T AT E221771 T1 ATE221771 T1 AT E221771T1
- Authority
- AT
- Austria
- Prior art keywords
- composition
- drug
- pct
- controlling agent
- gastrointestinal tract
- Prior art date
Links
- 238000013270 controlled release Methods 0.000 title abstract 2
- 210000001035 gastrointestinal tract Anatomy 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 6
- 229940079593 drug Drugs 0.000 abstract 6
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 239000002702 enteric coating Substances 0.000 abstract 2
- 238000009505 enteric coating Methods 0.000 abstract 2
- 239000008187 granular material Substances 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- WXGVASWIUBFCHW-UHFFFAOYSA-N 3-(2-acetyl-3-oxobut-1-enyl)benzonitrile Chemical compound CC(=O)C(C(C)=O)=CC1=CC=CC(C#N)=C1 WXGVASWIUBFCHW-UHFFFAOYSA-N 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 210000003750 lower gastrointestinal tract Anatomy 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI951316A FI98343C (fi) | 1995-03-21 | 1995-03-21 | Peroraalinen formulaatio |
| PCT/FI1996/000164 WO1996029058A1 (en) | 1995-03-21 | 1996-03-20 | Peroral composition for controlled release in the lower gastrointestinal tract |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE221771T1 true ATE221771T1 (de) | 2002-08-15 |
Family
ID=8543092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96906784T ATE221771T1 (de) | 1995-03-21 | 1996-03-20 | Perorale zusammensetzung zur kontrollierten freisetzungen in dem unteren teil des gastrointestinaltraktes |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5962024A (de) |
| EP (1) | EP0817615B1 (de) |
| JP (1) | JPH11502217A (de) |
| AT (1) | ATE221771T1 (de) |
| AU (1) | AU694849B2 (de) |
| CA (1) | CA2213747A1 (de) |
| DE (1) | DE69622850T2 (de) |
| DK (1) | DK0817615T3 (de) |
| ES (1) | ES2181874T3 (de) |
| FI (1) | FI98343C (de) |
| IL (1) | IL117582A (de) |
| NO (1) | NO312705B1 (de) |
| NZ (1) | NZ303683A (de) |
| PT (1) | PT817615E (de) |
| WO (1) | WO1996029058A1 (de) |
| ZA (1) | ZA962271B (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998024412A2 (en) * | 1996-12-05 | 1998-06-11 | The Board Of Trustees Of The University Of Illinois | Compounds useful against diseases of the colon and methods for orally administering same |
| DE19732903A1 (de) | 1997-07-30 | 1999-02-04 | Falk Pharma Gmbh | Pellet-Formulierung zur Behandlung des Intestinaltraktes |
| US6110500A (en) * | 1998-03-25 | 2000-08-29 | Temple University | Coated tablet with long term parabolic and zero-order release kinetics |
| AU2003268330A1 (en) * | 2002-08-29 | 2004-03-19 | Activbiotics, Inc. | Methods and reagents for treating infections of clostridium difficile and diseases associated therewith |
| US20050025829A1 (en) * | 2003-07-29 | 2005-02-03 | Kim Cherng-Ju | Controlled drug release tablets |
| ES2359375T3 (es) * | 2003-11-04 | 2011-05-20 | Supernus Pharmaceuticals, Inc. | Formas de dosificación de dosis única diaria de trospio. |
| US8709476B2 (en) | 2003-11-04 | 2014-04-29 | Supernus Pharmaceuticals, Inc. | Compositions of quaternary ammonium compounds containing bioavailability enhancers |
| US20060159753A1 (en) * | 2004-12-27 | 2006-07-20 | Eisai Co. Ltd. | Matrix type sustained-release preparation containing basic drug or salt thereof |
| EP1830886B1 (de) | 2004-12-27 | 2016-04-13 | Eisai R&D Management Co., Ltd. | Verfahren zur stabilisierung eines arzneimittels gegen demenz |
| EP1912629A4 (de) * | 2005-07-08 | 2012-09-12 | Univ Arkansas | Asymmetrisch beschichtete tablette |
| US20080139526A1 (en) * | 2006-12-06 | 2008-06-12 | Donald Treacy | Modified release dosage forms of amoxicillin |
| US8357394B2 (en) * | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
| US8299052B2 (en) * | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
| US7713549B2 (en) * | 2006-06-30 | 2010-05-11 | Board Of Trustees Of The University Of Arkansas | Extended release perforated tablet |
| US20090036414A1 (en) * | 2007-08-02 | 2009-02-05 | Mutual Pharmaceutical Company, Inc. | Mesalamine Formulations |
| EA022886B1 (ru) | 2008-10-03 | 2016-03-31 | Др. Фальк Фарма Гмбх | Способ поддержания ремиссии язвенного колита у пациентов |
| CN102988318A (zh) * | 2008-11-25 | 2013-03-27 | 田边三菱制药株式会社 | 口腔速崩片及其制备方法 |
| CA3107450A1 (en) | 2012-03-29 | 2013-10-03 | Therabiome, Llc | Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix |
| NZ711298A (en) | 2013-03-14 | 2021-07-30 | Therabiome Llc | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
| EP3684344A4 (de) * | 2017-10-25 | 2020-11-18 | Chiesi Farmaceutici S.p.A. | Deferiprontabletten mit verzögerter freisetzung und verfahren zu ihrer verwendung |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9002337D0 (en) * | 1990-02-02 | 1990-04-04 | Orion Yhtymae Oy | Compounds useful in treating inflammatory bowel disease |
| PT93637A (pt) * | 1989-04-20 | 1990-11-20 | Procter & Gamble | Metodo para o tratamento de desordens funcionais intestinais/colonicas, especialmente o sindrome de irritacao intestinal |
| JPH0334928A (ja) * | 1989-06-29 | 1991-02-14 | Teikoku Seiyaku Kk | 潰瘍性大腸炎およびクローン病治療用経口投与製剤 |
| US5209933A (en) * | 1990-01-10 | 1993-05-11 | Syntex (U.S.A.) Inc. | Long acting calcium channel blocker composition |
| AU1587392A (en) * | 1991-03-15 | 1992-10-21 | Norwich Eaton Pharmaceuticals, Inc. | The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d) |
| SE501389C2 (sv) * | 1992-04-24 | 1995-01-30 | Leiras Oy | Farmaceutiskt preparat och förfarande för dess framställning |
-
1995
- 1995-03-21 FI FI951316A patent/FI98343C/fi not_active IP Right Cessation
-
1996
- 1996-03-20 CA CA002213747A patent/CA2213747A1/en not_active Abandoned
- 1996-03-20 ES ES96906784T patent/ES2181874T3/es not_active Expired - Lifetime
- 1996-03-20 DK DK96906784T patent/DK0817615T3/da active
- 1996-03-20 WO PCT/FI1996/000164 patent/WO1996029058A1/en active IP Right Grant
- 1996-03-20 JP JP8528112A patent/JPH11502217A/ja not_active Ceased
- 1996-03-20 DE DE69622850T patent/DE69622850T2/de not_active Expired - Fee Related
- 1996-03-20 AT AT96906784T patent/ATE221771T1/de not_active IP Right Cessation
- 1996-03-20 AU AU50061/96A patent/AU694849B2/en not_active Ceased
- 1996-03-20 IL IL11758296A patent/IL117582A/xx not_active IP Right Cessation
- 1996-03-20 PT PT96906784T patent/PT817615E/pt unknown
- 1996-03-20 ZA ZA962271A patent/ZA962271B/xx unknown
- 1996-03-20 NZ NZ303683A patent/NZ303683A/en unknown
- 1996-03-20 US US08/913,554 patent/US5962024A/en not_active Expired - Fee Related
- 1996-03-20 EP EP96906784A patent/EP0817615B1/de not_active Expired - Lifetime
-
1997
- 1997-08-27 NO NO19973950A patent/NO312705B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU694849B2 (en) | 1998-07-30 |
| NO973950D0 (no) | 1997-08-27 |
| IL117582A0 (en) | 1996-07-23 |
| AU5006196A (en) | 1996-10-08 |
| US5962024A (en) | 1999-10-05 |
| EP0817615A2 (de) | 1998-01-14 |
| WO1996029058A1 (en) | 1996-09-26 |
| NO312705B1 (no) | 2002-06-24 |
| FI98343B (fi) | 1997-02-28 |
| DK0817615T3 (da) | 2002-11-25 |
| FI951316A0 (fi) | 1995-03-21 |
| ES2181874T3 (es) | 2003-03-01 |
| DE69622850T2 (de) | 2003-04-24 |
| FI98343C (fi) | 1997-06-10 |
| DE69622850D1 (de) | 2002-09-12 |
| FI951316A (fi) | 1996-09-22 |
| PT817615E (pt) | 2002-12-31 |
| EP0817615B1 (de) | 2002-08-07 |
| IL117582A (en) | 2000-02-29 |
| NZ303683A (en) | 1998-07-28 |
| JPH11502217A (ja) | 1999-02-23 |
| CA2213747A1 (en) | 1996-09-26 |
| NO973950L (no) | 1997-08-27 |
| ZA962271B (en) | 1996-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE221771T1 (de) | Perorale zusammensetzung zur kontrollierten freisetzungen in dem unteren teil des gastrointestinaltraktes | |
| ATE225165T1 (de) | Im unteren teil des verdauungstrakts freisetzende pharmazeutische zubereitung in form einer beschichteten kapsel | |
| DE69630375D1 (de) | Pharmazeutische dosierungsform zur freisetzung im colon | |
| DE69619668D1 (de) | Pharmazeutische dosisform mit mehrfacher darmlöslicher polymerbeschichtung zur wirkstoffabgabe im kolon | |
| DE69719774D1 (de) | Pharmazeutische dosierungsform mit mehrfachen enterischen polymer-überzügenzur abgabe im kolon | |
| DE69636724D1 (de) | Drei verschiedene polymertypen enthaltende formulierung mit verzögerter freigabe | |
| NZ511448A (en) | A dosage form of diltiazem that exhibits a release rate profile corresponding to a "two peak" plasma level profile in vivo | |
| ATE361061T1 (de) | Beschichtungszusammensetzung zur geschmacksmaskierung | |
| AU2001291526A1 (en) | Sustained release composition containing clarithromycin | |
| ATE235232T1 (de) | Lutschtablette zur modifizierten freisetzung von wirkstoffen im gastrointestinaltrakt | |
| BR9806174A (pt) | Péletes tendo um núcleo revestido com um antifúngico e um polìmero | |
| ES2130278T3 (es) | Preparacion de morfina de liberacion controlada. | |
| DE60019116D1 (de) | Neue omeprazole und (s)-omeprazole zusammensetzung | |
| DE69630215D1 (de) | Diltiazem-formulierung mit gesteuerter freigabe | |
| NZ260365A (en) | Controlled release drug delivery device; solid core, delay coating, semi-permeable membrane, outer enteric coating | |
| DE69622510D1 (de) | Nifedipinzubereitung mit langanhaltender Freisetzung | |
| CA2268868A1 (en) | Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery | |
| CA2271569A1 (en) | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery | |
| CA2271560A1 (en) | Pharmaceutical dosage form for colonic delivery | |
| NO992349L (no) | Farmas°ytisk doseform for avlevering i tykktarmen | |
| KR970032869A (ko) | 딜티아젬의 서방형 펠렛 제형 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |